Who owns FOCUS PHARMACEUTICALS LIMITED?

In the current sources, FOCUS PHARMACEUTICALS LIMITED is connected to The Blackstone Group Inc., The Blackstone Group Inc., MERCURY PHARMA GROUP LIMITED, The Blackstone Group Inc., The Blackstone Group Inc.. Trace the full chain to the ultimate beneficial owner in the WhiteIntel ownership graph.

What is FOCUS PHARMACEUTICALS LIMITED's risk level?

WhiteIntel flags FOCUS PHARMACEUTICALS LIMITED as low risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.

Where does FOCUS PHARMACEUTICALS LIMITED appear across sources?

FOCUS PHARMACEUTICALS LIMITED is indexed in the WhiteIntel corporate-ownership graph (GB), with a source on every claim.

LIVE · CORPUS

SnitchScore · reading…

evidence coverage · reading…

Coverage — measured

Sources fused: 2
Ownership hops held: 12

An absent edge means not yet observed — never does not exist.

Legal entityLowActive

FOCUS PHARMACEUTICALS LIMITED

Name: FOCUS PHARMACEUTICALS LIMITED — ownership dossier
Creator: WhiteIntel
License: https://whiteintel.dev/terms
Keywords: corporate ownership, beneficial ownership, UBO, corporate intelligence, OSINT, corporate registry, FOCUS PHARMACEUTICALS LIMITED, Company, GB

FOCUS PHARMACEUTICALS LIMITED — active UK company, incorporated 2002 (oo:GB-COH-04522142). UBO chain traced 12 hops, 5 owners, 20 officers. Cited to 2…

OO GB-COH-04522142Inc. 30 Aug 2002ltdGB

Ownership graph Export .md

JSON / MCPsample

Live UK registry

The finding

Ownership resolves 12 hops deep toward the ultimate beneficial owner.

Investigative lead by resolved identity, not a legal determination.

/01

Registry identity

Status: active
Incorporated: 2002-08-30
Legal form: ltd
Activity: 21200, 46460, 72190
Registered office: Dashwood House, 69 Old Broad Street, London, EC2M 1QS, United Kingdom

/02

Ownership & control

Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.

Owners / controllers

FOCUS PHARMACEUTICALS LIMITED
- The Blackstone Group Inc.· beneficial owner100%· via OpenOwnership
- The Blackstone Group Inc.· beneficial owner37.5%· via CH PSC
- MERCURY PHARMA GROUP LIMITED· beneficial owner87.5%· via CH PSC

Holdings / subsidiaries

None in current sources.

Walk the full UBO chain

12 hops lockedDOSSIER

12-step ownership / control trace to the ultimate beneficial owner — cited at every hop. Unlock the full chain.

Unlock Verified Dossier€29

Verified Dossier€29

Everything we hold on this subject, for one price — every hop to the ultimate owner, filing history, sanctions exposure, and the asset layer (property, vessels, aircraft) — as PDF and JSON, every claim linked to its source.

Everything we hold on FOCUS PHARMACEUTICALS LIMITED, resolved and sourced — yours to keep, no subscription.

INCLUDED WHEN YOU UNLOCK

UBO trace
Branded PDF + un-redacted JSON · every claim linked to its source
Re-download for 90 days

UBO trace

Guest checkout · email only · re-download 90 days. Or subscribe from €99.

WHAT YOU CAN SEEFREE

YOURS NOW · FREE

4 items you can read right now — no account, no payment.

Identity, address & registry profile
Sanctions & watchlist detail
Direct connections (1 hop)
Community notes

YOURS AFTER YOU UNLOCK · PAID

2 more items, hidden until you unlock this dossier. The badge on each row names the dossier that includes it.

Full ownership trace to the UBODOSSIER
Full export (PDF + un-redacted JSON) & change alertsDOSSIER

/03

Register record, filings & financials

live · Companies House

Company no.: 04522142
Status: active
Type: ltd
Incorporated: 2002-08-30
Registered office: Dashwood House, 69 Old Broad Street, London, EC2M 1QS, United Kingdom
SIC: 21200, 46460, 72190

/04

People & control

20 parties · 4 current

Every officer, person with significant control and cross-company role we hold, resolved into one entry per party. Roles are registry records, not a claim of control.

●
IDRIS, Amaar Fainan
- director · British · appointed 2025-02-06 · Companies House
■
Mercury Pharma Group Limited
- corporate PSC · 75–100% shares · United Kingdom · since 2021-12-16 · CH · PSC register
Also holds roles at 9 other companies
- The Blackstone Group Inc.beneficial owner
- ADVANZ PHARMA UK AND IRELAND LIMITEDbeneficial owner
- MERCURY PHARMACEUTICALS LIMITEDbeneficial owner
●
STICKLER, Andreas
- director · German · appointed 2022-01-21 · Companies House
●
TMF CORPORATE ADMINISTRATION SERVICES LIMITED
- corporate secretary · appointed 2022-03-16 · Companies House
●
AHMAD, Adeel
- director · Canadian · appointed 2016-01-08 · resigned · Companies House
●
BEIGHTON, John
- director · British · appointed 2014-10-01 · resigned · Companies House
●
BROWN, Roland Alexander
- director · British · appointed 2002-10-28 · resigned · Companies House
●
CRESSWELL, Mark
- director · British · appointed 2002-10-28 · resigned · Companies House
●
DUNCAN, Graeme Neville
- director · British · appointed 2018-11-30 · resigned · Companies House
- director · British · appointed 2016-12-31 · resigned · Companies House
■
Focus Pharma Holdings Limited
- corporate PSC · 75–100% shares · England · ceased 2021-12-16 · CH · PSC register
- corporate PSC · 75–100% shares · England · ceased 2020-03-27 · CH · PSC register
●
FORM 10 SECRETARIES FD LTD
- corporate nominee secretary · appointed 2002-08-30 · resigned · Companies House
●
GRETHE, Richard Paul
- secretary · British · appointed 2004-12-01 · resigned · Companies House
- director · British · appointed 2004-12-01 · resigned · Companies House
●
KAMATH, Vikram Laxman
- director · British · appointed 2016-12-31 · resigned · Companies House
●
LEAVER, Andrew Derrick
- director · British · appointed 2002-10-28 · resigned · Companies House
●
LEAVER, Linda
- secretary · British · appointed 2002-10-28 · resigned · Companies House
●
MAGINLEY, Bronson Raymond
- secretary · British · appointed 2003-10-01 · resigned · Companies House
- director · British · appointed 2002-10-28 · resigned · Companies House
●
SULLY, Robert
- secretary · appointed 2018-10-01 · resigned · Companies House
●
SULLY, Robert James
- secretary · appointed 2014-10-01 · resigned · Companies House
■
The Blackstone Group Inc.
- corporate PSC · 25–50% shares · United States · ceased 2021-06-01 · CH · PSC register
Also holds roles at 19 other companies
- MERCURY PHARMA GROUP LIMITEDbeneficial owner
- The Blackstone Group Inc.beneficial owner
- ONYX GERMANY (3) LTDbeneficial owner
●
WILLIAMS, David Richard
- secretary · appointed 2016-12-31 · resigned · Companies House

20 parties · 4 current. Ceased and resigned records are retained as history.

/05

Common questions

Who owns FOCUS PHARMACEUTICALS LIMITED?: In the current sources, FOCUS PHARMACEUTICALS LIMITED is connected to The Blackstone Group Inc., The Blackstone Group Inc., MERCURY PHARMA GROUP LIMITED, The Blackstone Group Inc., The Blackstone Group Inc.. Trace the full chain to the ultimate beneficial owner in the WhiteIntel ownership graph.
What is FOCUS PHARMACEUTICALS LIMITED's risk level?: WhiteIntel flags FOCUS PHARMACEUTICALS LIMITED as low risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.
Where does FOCUS PHARMACEUTICALS LIMITED appear across sources?: FOCUS PHARMACEUTICALS LIMITED is indexed in the WhiteIntel corporate-ownership graph (GB), with a source on every claim.

Community intel

Crowd leads · unverified

Tips, corrections and leads contributed by the community on FOCUS PHARMACEUTICALS LIMITED. These are unverified leads, not WhiteIntel findings — we surface them for investigators to chase, and analyse the corroborated ones into SnitchScore.

Loading tips…

Is this your company?

Open the inbox for this record, read what has been put to it, and answer on the record. You will be asked to show that you can act for FOCUS PHARMACEUTICALS LIMITED — nothing is disclosed before that.

Claim this record